FDG is used to study glucose metabolism, which can be increased in cases of tumors or inflammations, for example. In FDG-PET examination of the brain, areas with reduced glucose metabolism are of particular interest, for instance, in the diagnosis of epilepsy and dementia.
You will need: a referral (detailed question), previous images/reports, creatinine value (which can also be taken and checked by us), and the completed questionnaires. You should not eat any food 12 hours before the examination (water, medication are allowed).
The examination consists of three phases: In the preparation phase, the radioactive substance is specially prepared for each patient and then administered (usually intravenously). The technical phase includes the implementation of scintigraphy, SPECT, or PET measurements including image evaluation. The information phase (medical reporting) concludes the process.
You will receive a minimal amount of a radioactive substance (radiopharmaceutical) with a short half-life. After 20 -240 minutes, it has sufficiently accumulated in the target organ and the examination can be carried out.
These examinations are conducted by the nuclear medicine department. These examinations are privately paid, and can be submitted to a supplementary/private insurance.